Morice Yoann, Roulot Dominique, Grando Véronique, Stirnemann Jérome, Gault Elyanne, Jeantils Vincent, Bentata Michelle, Jarrousse Bernard, Lortholary Olivier, Pallier Coralie, Dény Paul
Laboratoire de Bactériologie, Virologie-Hygiène, Hôpital Avicenne, Equipe d'accueil Agents Transmissibles et Hôtes, Signalisation Cellulaire et Oncogenese, UFR Santé Médecine Biologie Humaine, Université Paris 13, Bobigny, France1.
Services d'Hépatologie-Gastroentérologie, Réseau hépatite C Nord-Est Parisien, Hôpitaux Avicenne et Jean Verdier, UFR Santé Médecine Biologie Humaine, Université Paris 13, Bobigny et Bondy, France2.
J Gen Virol. 2001 May;82(Pt 5):1001-1012. doi: 10.1099/0022-1317-82-5-1001.
Hepatitis C virus (HCV) has been classified into six clades as a result of high genetic variability. In the Seine-Saint-Denis district of north-east Paris, the prevalence of HCV-4, which usually infects populations from Africa or the Middle East, is twice as high as that recorded for the whole of continental France (10.2 versus 4.5%). Although the pathogenicity of HCV-4 remains unknown, resistance of HCV-4 to therapy appears to be similar to that observed for HCV-1. In order to characterize the epidemiology of HCV-4 in Paris, sequences of the non-structural 5B gene (332 bp) were obtained from 38 HCV-4-infected patients. Extensive phylogenetic analyses indicated seven different HCV-4 subtypes. Moreover, phylogenetic tree topologies clearly distinguished two epidemiological profiles. The first profile (52.6% of patients) reflects the intra-suburban emergence of two distinct HCV-4 subclades occurring mainly among intravenous drug users (65% of patients). The second profile shows six subclades [HCV-4a, -4f, -4h, -4k, -4a(B) and a new sequence] and accounts for patients from Africa (Egypt and sub-Saharan countries) who have unknown risk factors (77.8% of patients) and in whom no recent diffusion of HCV-4 is evident. This study indicates the high diversity of HCV-4 and the extension of HCV-4a and -4d subclades among drug users in FRANCE:
由于高度的基因变异性,丙型肝炎病毒(HCV)已被分为六个进化枝。在巴黎东北部的塞纳-圣但尼区,通常感染非洲或中东人群的HCV-4的流行率是整个法国大陆记录水平的两倍(10.2%对4.5%)。尽管HCV-4的致病性尚不清楚,但HCV-4对治疗的耐药性似乎与HCV-1相似。为了描述巴黎HCV-4的流行病学特征,从38例HCV-4感染患者中获得了非结构5B基因(332bp)的序列。广泛的系统发育分析表明有七种不同的HCV-4亚型。此外,系统发育树拓扑结构清楚地区分了两种流行病学特征。第一种特征(52.6%的患者)反映了在郊区内出现的两个不同的HCV-4亚进化枝,主要发生在静脉吸毒者中(65%的患者)。第二种特征显示有六个亚进化枝[HCV-4a、-4f、-4h、-4k、-4a(B)和一个新序列],占来自非洲(埃及和撒哈拉以南国家)且危险因素不明的患者(77.8%的患者),在这些患者中没有明显的近期HCV-4传播。这项研究表明HCV-4具有高度多样性,并且HCV-4a和-4d亚进化枝在法国吸毒者中有所扩展: